Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus Therapy
Researchers from St. Louis University report recent findings in hepatitis C virus therapy
August 6th, 2007
Investigators publish new data in the report "Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy." According to a study from the United States, "Pegylated alpha interferon and ribavirin therapy for hepatitis C virus (HCV) genotype 1 infection fails for half of Caucasian American patients (CA) and more often for African Americans (AA). The reasons for these low response rates are unknown." "HCV is highly genetically variable, but it is unknown how this variability affects response to therapy. To assess effects of viral diversity on response to therapy, the complete pretreatment...
Source: Hepatitis Weekly (2007-08-06)
|
